Decoding MHT Menopause Hormone Therapy Myths & Facts

In the third episode of this series on MHT, We discuss the critical topic of the history of women and people with uteruses and ovaries in clinical research. The episode dives into how these groups were only regularly included in clinical studies from the 1990s and discusses the consequences of this. Bree Luck unpacks the effects of this shift on menopausal hormone therapy, its efficacy, risks involved, and also the terms often involved in understanding related studies. The episode stresses the importance of accurate and diverse data in medical research. Bree further explores the early stages of understanding menopause and the role of estrogen in treating its symptoms. The host also discusses the challenges and scrutiny faced in the research of hormone therapy, especially in relation to chronic disease prevention. The episode emphasises personalisation and careful consideration in the decision to use Menopausal Hormone Therapy (MHT). Also, concerns surrounding bio-identical hormones are briefly touched upon. Finally, the host encourages listeners to engage with the 'Pause to Go' community, sharing experiences and fostering support.   0:00 Decoding MHT Part 3 00:02 Introduction to the Podcast 00:44 The History of Women in Clinical Research 02:40 A Shoutout to Supporters ( Buy me a coffee.  ) 03:21 The Women's Health Movement in the 70s 05:17 The Fight for Inclusion in Clinical Trials 06:01 The Impact of the NIH Revitalization Act of 1993 08:32 The Journey from Exclusion to Inclusion 08:59 A Look Back at Hormone Herstory 09:35 The Controversy Surrounding Hormone Replacement Therapy 13:27 The Women's Health Initiative and Its Impact 16:02 The Current State of Menopausal Hormone Therapy 17:16 The Importance of Personalized Medicine 19:17 A Note on Bioidentical Hormones 19:46 Final Thoughts on Menopausal Hormone Therapy 20:19 Community Support and Engagement 21:08 Closing Remarks and Preview of Next Episode   References:  1. https://www.fda.gov/science-research/womens-health-research/gender-studies-product-development-historical-overview 2. https://www.fda.gov/science-research/womens-health-research/gender-studies-product-development-historical-overview 3. https://www.nbcnews.com/id/wbna16397237 4.  Robert A. Wilson (1966). Feminine Forever. M. Evans and Company. ISBN 978-0-87131-049-1. OCLC 10373653. OL 5982073M. 5. Ziel H.K., Finkle W.D. Increased risk on endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 1975;293:1167–1170. doi: 10.1056/NEJM197512042932303. [PubMed] [CrossRef] [Google Scholar] [Ref list] 6. https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/hormone-therapy-benefits-risks 7. https://www.contemporaryobgyn.net/view/new-hormone-therapy-guidelines-from-the-north-american-menopause-society 8. https://www.hsph.harvard.edu/news/hsph-in-the-news/hormonal-therapy-menopause/ Wanna connect with Bree? (I'm here for it!!!)   Find me on Instagram: https://www.instagram.com/awkwardsagemedia/   Find me on LinkedIn: https://www.linkedin.com/in/breeluck/   Awkward Sage Media: www.awkwardsage.com   The Lovely Unbecoming Coaching Services: Explore your Inner Role System with Bree https://calendly.com/awkwardsage/90-minute-session Want to Support the Pause to Go Podcast? Here are three ways: 1. Leave a written review on Apple Podcasts or drop 5 stars on Spotify 2. Send me a voice memo, letting me know your thoughts about the show 3. Buy me a coffee.  A little caffeine goes a long way to ignite midlife convos.